Literature DB >> 25483470

Does intention to recommend HPV vaccines impact HPV vaccination rates?

Kristen A Feemster1, Maria Middleton, Alexander G Fiks, Sarah Winters, Sara B Kinsman, Jessica A Kahn.   

Abstract

Despite recommendations for routine vaccination, HPV vaccination rates among adolescent females have remained low. The objective of this prospective cohort study was to determine whether clinician intention to recommend HPV vaccines predicts HPV vaccine series initiation among previously unvaccinated 11 to 18 year-old girls (N=18,083) who were seen by a pediatric clinician (N=105) from a large primary care network within 3 years of vaccine introduction. We used multivariable logistic regression with generalized estimating equations, Cox Regression and standardized survival curves to measure the association between clinician intention and time to and rate of first HPV vaccine receipt among eligible females. All models adjusted for patient age, race/ethnicity, payor category, visit type, and practice location. Eighty-5 percent of eligible 11 to 12 year-old and 95% of 13 to 18 year-old girls were seen by a provider reporting high intention to recommend HPV vaccines. However, only 30% of the cohort initiated the HPV vaccine series and the mean number of days from first eligible visit to series initiation was 190 (95% C.I. 184.2, 195.4). After adjusting for covariates, high clinician intention was modestly associated with girls' likelihood of HPV vaccine series initiation (OR 1.36; 95 % C.I. 1.07, 1.71) and time to first HPV vaccination (HR 1.22; 95% 1.06, 1.40). Despite high intention to vaccinate among this cohort of pediatric clinicians, overall vaccination rates for adolescent girls remained low. These findings support ongoing efforts to develop effective strategies to translate clinician intention into timely HPV vaccine receipt.

Entities:  

Keywords:  EMR, Electronic Medical Record; HPV, Human papillomavirus; Human papillomavirus; adolescent health; human papillomavirus vaccines; immunizations; preventive care

Mesh:

Substances:

Year:  2014        PMID: 25483470      PMCID: PMC4977433          DOI: 10.4161/21645515.2014.969613

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  55 in total

Review 1.  How society should respond to the risk of vaccine rejection.

Authors:  David Ropeik
Journal:  Hum Vaccin Immunother       Date:  2013-06-06       Impact factor: 3.452

2.  Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt.

Authors:  Alexander G Fiks; Robert W Grundmeier; Stephanie Mayne; Lihai Song; Kristen Feemster; Dean Karavite; Cayce C Hughes; James Massey; Ron Keren; Louis M Bell; Richard Wasserman; A Russell Localio
Journal:  Pediatrics       Date:  2013-05-06       Impact factor: 7.124

3.  Use of the Wei-Lin-Weissfeld method for the analysis of a recurring and a terminating event.

Authors:  Q H Li; S W Lagakos
Journal:  Stat Med       Date:  1997-04-30       Impact factor: 2.373

4.  Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health.

Authors:  May Lau; Hua Lin; Glenn Flores
Journal:  Vaccine       Date:  2012-03-15       Impact factor: 3.641

5.  Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital.

Authors:  Nicholas H Schluterman; Mishka Terplan; Alison D Lydecker; J Kathleen Tracy
Journal:  Vaccine       Date:  2011-04-06       Impact factor: 3.641

6.  National patterns in human papillomavirus vaccination: an analysis of the National Survey of Family Growth.

Authors:  Gelareh Sadigh; Amanda F Dempsey; Mack Ruffin; Ken Resnicow; Ruth C Carlos
Journal:  Hum Vaccin Immunother       Date:  2012-02-01       Impact factor: 3.452

7.  Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses.

Authors:  Lea E Widdice; David I Bernstein; Anthony C Leonard; Keith A Marsolo; Jessica A Kahn
Journal:  Pediatrics       Date:  2010-12-13       Impact factor: 7.124

Review 8.  Factors associated with HPV vaccine uptake in teenage girls: a systematic review.

Authors:  Sharon J M Kessels; Helen S Marshall; Maureen Watson; Annette J Braunack-Mayer; Rob Reuzel; Rebecca L Tooher
Journal:  Vaccine       Date:  2012-04-03       Impact factor: 3.641

9.  Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.

Authors:  Stan L Block; Terry Nolan; Carlos Sattler; Eliav Barr; Katherine E D Giacoletti; Colin D Marchant; Xavier Castellsagué; Steven A Rusche; Suzanne Lukac; Janine T Bryan; Paul F Cavanaugh; Keith S Reisinger
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

10.  Effective messages in vaccine promotion: a randomized trial.

Authors:  Brendan Nyhan; Jason Reifler; Sean Richey; Gary L Freed
Journal:  Pediatrics       Date:  2014-03-03       Impact factor: 7.124

View more
  1 in total

1.  Japanese physicians' attitudes and intentions regarding human papillomavirus vaccine compared with other adolescent vaccines.

Authors:  Tomohiro Katsuta; Charlotte A Moser; Paul A Offit; Kristen A Feemster
Journal:  Papillomavirus Res       Date:  2019-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.